Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Mirum Pharmaceuticals Inc shares valued at $152,256 were sold by Radovich Peter on Jan 24 ’25. At $47.92 per share, Radovich Peter sold 3,177 shares. The insider’s holdings dropped to 29,588 shares worth approximately $1.43 million following the completion of this transaction.
Also, Howe Jolanda sold 902 shares, netting a total of over 43,228 in proceeds. Following the sale of shares at $47.92 each, the insider now holds 3,524 shares.
Before that, Peetz Christopher had sold 6,837 shares from its account. In a trade valued at $327,658, the CHIEF EXECUTIVE OFFICER traded Mirum Pharmaceuticals Inc shares for $47.92 each. Upon closing the transaction, the insider’s holdings decreased to 6,837 shares, worth approximately $6.06 million.
As published in their initiating research note from Stifel on April 17, 2024, Mirum Pharmaceuticals Inc [MIRM] has been a Buy and the price target has been revised to $48. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in mid December. Earlier on November 13, 2023, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for MIRM stock.
Analyzing MIRM Stock Performance
During the last five days, there has been a drop of approximately -0.43%. Over the course of the year, Mirum Pharmaceuticals Inc shares have jumped approximately 17.15%. Shares of the company reached a 52-week high of $49.58 on 01/28/25 and a 52-week low of $40.55 on 01/10/25. A 50-day SMA is recorded $44.15, while a 200-day SMA reached $37.41. Nevertheless, trading volume fell to 0.71 million shares from 0.26 million shares the previous day.
Support And Resistance Levels for Mirum Pharmaceuticals Inc (MIRM)
According to the 24-hour chart, there is a support level at 47.94, which, if violated, would cause prices to drop to 47.43. In the upper region, resistance lies at 49.03. The next price resistance is at 49.61. RSI (Relative Strength Index) is 63.96 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.91, which suggests the price will increase in the coming days. Percent R is at 12.62%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
